Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylation

BackgroundThe Epstein-Barr virus (EBV)-encoded EBNA1 protein is expressed in all EBV-associated tumours, including undifferentiated nasopharyngeal carcinoma (NPC), where it is indispensable for viral replication, genome maintenance and viral gene expression. EBNA1's transcription factor-like functions also extend to influencing the expression of cellular genes involved in pathways commonly dysregulated during oncogenesis, including elevation of AP-1 activity in NPC cell lines resulting in enhancement of angiogenesis in vitro. In this study we sought to extend these observations by examining the role of EBNA1 upon another pathway commonly deregulated during carcinogenesis; namely NF-κB.ResultsIn this report we demonstrate that EBNA1 inhibits the canonical NF-κB pathway in carcinoma lines by inhibiting the phosphorylation of IKKα/β. In agreement with this observation we find a reduction in the phosphorylation of IκBα and reduced phosphorylation and nuclear translocation of p65, resulting in a reduction in the amount of p65 in nuclear NF-κB complexes. Similar effects were also found in carcinoma lines infected with recombinant EBV and in the EBV-positive NPC-derived cell line C666-1. Inhibition of NF-κB was dependent upon regions of EBNA1 essential for gene transactivation whilst the interaction with the deubiquitinating enzyme, USP7, was entirely dispensable. Furthermore, in agreement with EBNA1 inhibiting p65 NF-κB we demonstrate that p65 was exclusively cytoplasmic in 11 out of 11 NPC tumours studied.ConclusionsInhibition of p65 NF-κB in murine and human epidermis results in tissue hyperplasia and the development of squamous cell carcinoma. In line with this, p65 knockout fibroblasts have a transformed phenotype. Inhibition of p65 NF-κB by EBNA1 may therefore contribute to the development of NPC by inducing tissue hyperplasia. Furthermore, inhibition of NF-κB is employed by viruses as an immune evasion strategy which is also closely linked to oncogenesis during persistent viral infection. Our findings therefore further implicate EBNA1 in playing an important role in the pathogenesis of NPC.

[1]  L. Young,et al.  Epstein–Barr virus and oncogenesis: from latent genes to tumours , 2003, Oncogene.

[2]  R. Pathmanathan,et al.  Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. , 2003, Cancer research.

[3]  D. Rea,et al.  Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer , 2007, British Journal of Cancer.

[4]  K. Takada,et al.  Epstein-Barr Virus Contributes to the Malignant Phenotype and to Apoptosis Resistance in Burkitt’s Lymphoma Cell Line Akata , 1998, Journal of Virology.

[5]  H. Kwon,et al.  Hostile takeovers: viral appropriation of the NF-kB pathway , 2001 .

[6]  L. Young,et al.  Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. , 2008, The Journal of general virology.

[7]  J. Anrather,et al.  Termination of NF-κB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase , 2009, The EMBO journal.

[8]  Jennifer Y. Zhang,et al.  NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. , 2003, Nature.

[9]  H. Kwon,et al.  Hostile takeovers: viral appropriation of the NF-kappaB pathway. , 2001, The Journal of clinical investigation.

[10]  Y. Fukui,et al.  Reactive nitrogen species‐dependent DNA damage in EBV‐associated nasopharyngeal carcinoma: The relation to STAT3 activation and EGFR expression , 2008, International journal of cancer.

[11]  M. Nishikori Classical and Alternative NF-κB Activation Pathways and Their Roles in Lymphoid Malignancies , 2005 .

[12]  J. Sixbey,et al.  Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2 , 1995, Journal of virology.

[13]  A. Levine,et al.  Expression of Epstein‐Barr virus nuclear antigen‐1 induces B cell neoplasia in transgenic mice. , 1996, The EMBO journal.

[14]  M. Karin NF‐κB and cancer: Mechanisms and targets , 2006 .

[15]  V. Diehl,et al.  Expression of Epstein-Barr Virus Nuclear Antigen 1 Is Associated with Enhanced Expression of CD25 in the Hodgkin Cell Line L428 , 1999, Journal of Virology.

[16]  J. Curnow,et al.  Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Jennifer Y. Zhang,et al.  NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia , 2003, Nature.

[18]  S. Cooray,et al.  Inhibition of IκB Kinase by Vaccinia Virus Virulence Factor B14 , 2008, PLoS pathogens.

[19]  J. Sample,et al.  Epstein-Barr Virus Small RNAs Potentiate Tumorigenicity of Burkitt Lymphoma Cells Independently of an Effect on Apoptosis , 2000, Journal of Virology.

[20]  G. Haegeman,et al.  Transcriptional activation of the NF‐κB p65 subunit by mitogen‐ and stress‐activated protein kinase‐1 (MSK1) , 2003, The EMBO journal.

[21]  M. Lipinski,et al.  Establishment and characterization of three transplantable EBV‐containing nasopharyngeal carcinomas , 1988, International journal of cancer.

[22]  E. Kieff Epstein-Barr virus and its replication , 1996 .

[23]  E. Kieff,et al.  Epstein-Barr Virus Nuclear Antigen 1 Does Not Cause Lymphoma in C57BL/6J Mice , 2008, Journal of Virology.

[24]  N. Raab-Traub Epstein-Barr virus in the pathogenesis of NPC. , 2002, Seminars in cancer biology.

[25]  C. Tsai,et al.  Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells. , 1999, Cancer research.

[26]  E. Kieff,et al.  Epstein–Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Bowie,et al.  Viral appropriation of apoptotic and NF‐κB signaling pathways , 2004, Journal of cellular biochemistry.

[28]  L. Young,et al.  Epstein–Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFβ signaling pathways , 2007, Oncogene.

[29]  G. Courtois,et al.  Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation , 1998, Cell.

[30]  M. Diaz-Meco,et al.  Phosphatidylcholine hydrolysis activates NF-kappa B and increases human immunodeficiency virus replication in human monocytes and T lymphocytes , 1993, Journal of virology.

[31]  P. Khavari,et al.  Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Robertson,et al.  EC5S Ubiquitin Complex Is Recruited by KSHV Latent Antigen LANA for Degradation of the VHL and p53 Tumor Suppressors , 2006, PLoS pathogens.

[33]  I. Ernberg,et al.  Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells. , 2008, The American journal of pathology.

[34]  L. Young,et al.  Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways. , 2007, Oncogene.

[35]  G. Courtois,et al.  Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. , 1998, Cell.

[36]  L. Frappier,et al.  HAUSP/USP7 as an Epstein-Barr virus target. , 2004, Biochemical Society transactions.

[37]  M. Karin NF-kappaB and cancer: mechanisms and targets. , 2006, Molecular carcinogenesis.

[38]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[39]  A. Zwergal,et al.  C/EBPβ Blocks p65 Phosphorylation and Thereby NF-κB-Mediated Transcription in TNF-Tolerant Cells1 , 2006, The Journal of Immunology.

[40]  C. Amici,et al.  NEW EMBO MEMBER’S REVIEW: NF-κB and virus infection: who controls whom , 2003 .

[41]  P. Khavari,et al.  Nuclear Factor κB Subunits Induce Epithelial Cell Growth Arrest , 2000 .

[42]  C. Sample,et al.  The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated , 1992, Journal of virology.

[43]  P. Khavari,et al.  Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB , 1998 .

[44]  D. Vereide,et al.  Identifying Sites Bound by Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) in the Human Genome: Defining a Position-Weighted Matrix To Predict Sites Bound by EBNA1 in Viral Genomes , 2009, Journal of Virology.

[45]  T. Gilmore,et al.  Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-κB have a malignantly transformed phenotype , 2002, Oncogene.

[46]  P. Brown,et al.  Modulation of Cellular and Viral Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.

[47]  T. Piolot,et al.  Mapping EBNA-1 Domains Involved in Binding to Metaphase Chromosomes , 1999, Journal of Virology.

[48]  Liat Amir-Zilberstein,et al.  Interplay between E-box and NF-κB in Regulation of A20 Gene by DRB Sensitivity-inducing Factor (DSIF)* , 2008, Journal of Biological Chemistry.

[49]  L. Frappier,et al.  Separation of the DNA Replication, Segregation, and Transcriptional Activation Functions of Epstein-Barr Nuclear Antigen 1 , 2002, Journal of Virology.